SINGAPORE (Nov 8): Specialty pharmaceutical firm iX Biopharma saw its net losses quadruple to $3.2 million for the 1Q18 ended September, widening from a net loss of $0.8 million a year ago.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe